author-photo

Peter V. Danenberg

University of Southern California

321

Papers

16732

Citations

Citation Trend

Filter By

Papers (321) Sort By

Journal Conference Others

P14.04 cfRNA from Liquid Biopsies Is More Abundant Than cfDNA, Informs Treatment Outcome and Is Concordant with Tissue

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expression with immunotherapy outcomes.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P1.01-68 Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD2.01 PD-L1 and Other Potential Predictive Biomarkers Measured in Plasma by RT-PCR in cfRNA and cfDNA to Monitor Clinical Responses in Metastatic Lung Cancer Patients

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Clinical verification of circulating tumor RNA (ctRNA) as novel pretreatment predictor and tool for quantitative monitoring of treatment response in metastatic colorectal cancer (mCRC): A biomarker study of the DEEPER trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Multiparametric liquid biopsy analysis in metastatic prostate cancer

2019 JCI insight
Show All
- Source
- Cite
- Save
Citations (27)
Use of cell-free circulating RNA (cfRNA) levels in plasma and expression of HER2 and PD-L1 to monitor disease status in metastatic cancer patients.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
PS5 New Biomarkers to Follow Therapy Response in Plasma of NSCLC Patients

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)